CD19-targeted CAR NK cell therapy shows promising one-year results in patients with B-cell malignancies
Researchers at the University of Texas MD Anderson Cancer Center reported promising results in a phase I/II trial of 37 ...
Researchers at the University of Texas MD Anderson Cancer Center reported promising results in a phase I/II trial of 37 ...
© 2023 Manhattan Tribune -By Millennium Press
© 2023 Manhattan Tribune -By Millennium Press